Cherkasy Regional Oncology Dispensary ( Site 0504)

Cherkassy, Cherkasy Oblast 18009

0 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61) — Completed